W R VOGLER - JoVE Visualize

Showing results (31-40 of 111) with videos related to

Pageof 12

Sort By:

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995

Selective inhibition of adhesion molecule expression by edelfosine (ET-18-OCH3) on human umbilical vein or microvascular endotheliumD C Bosse, J T Parker, W R Vogler, et al.

Cancer|September 1, 1979

Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanomaC A Presant, A A Bartolucci, R V Smalley, et al.

Cancer|March 15, 1989

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study GroupH M Lazarus, W R Vogler, C P Burns, et al.

Archives of Internal Medicine|May 1, 1980

Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factorE H Hirsh, W R Vogler, T P McDonald, et al.

Cancer Treatment Reports|December 1, 1977

Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II studyE Vélez-Garcia, W R Vogler, A A Bartolucci, et al.

Biochemical and Biophysical Research Communications|March 29, 1983

Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophilsD M Helfman, B D Appelbaum, W R Vogler, et al.

Biochemical Pharmacology|October 15, 1985

Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovaryH D Su, G J Mazzei, W R Vogler, et al.

Cancer Investigation|December 9, 1998

The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivoW R Vogler, J Liu, O Volpert, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1994

Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3F J Candal, D C Bosse, W R Vogler, et al.

Experimental Hematology|January 1, 1994

Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell linesM Shoji, T Fukuhara, E F Winton, et al.

Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:

Pageof 12

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995

Selective inhibition of adhesion molecule expression by edelfosine (ET-18-OCH3) on human umbilical vein or microvascular endotheliumD C Bosse, J T Parker, W R Vogler, et al.

Cancer|September 1, 1979

Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanomaC A Presant, A A Bartolucci, R V Smalley, et al.

Cancer|March 15, 1989

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study GroupH M Lazarus, W R Vogler, C P Burns, et al.

Archives of Internal Medicine|May 1, 1980

Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factorE H Hirsh, W R Vogler, T P McDonald, et al.

Cancer Treatment Reports|December 1, 1977

Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II studyE Vélez-Garcia, W R Vogler, A A Bartolucci, et al.

Biochemical and Biophysical Research Communications|March 29, 1983

Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophilsD M Helfman, B D Appelbaum, W R Vogler, et al.

Biochemical Pharmacology|October 15, 1985

Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovaryH D Su, G J Mazzei, W R Vogler, et al.

Cancer Investigation|December 9, 1998

The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivoW R Vogler, J Liu, O Volpert, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1994

Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3F J Candal, D C Bosse, W R Vogler, et al.

Experimental Hematology|January 1, 1994

Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell linesM Shoji, T Fukuhara, E F Winton, et al.

Pageof 12